Show simple item record

P386 Two year follow up of children with Inflammatory Bowel Disease (IBD) treated with vedolizumab and ustekinumab

dc.contributor.authorMardare, Ren_US
dc.contributor.authorBurgess, Nen_US
dc.contributor.authorStudart, Den_US
dc.contributor.authorDeb, Pen_US
dc.contributor.authorGasparetto, Men_US
dc.contributor.authorCroft, Nen_US
dc.contributor.authorNaik, Sen_US
dc.contributor.authorKadir, Aen_US
dc.date.accessioned2021-10-11T15:55:09Z
dc.date.available2021-10-11T15:55:09Z
dc.date.issued2021-05-27en_US
dc.identifier.issn1197-4982en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/74469
dc.format.extents397 - s398en_US
dc.titleP386 Two year follow up of children with Inflammatory Bowel Disease (IBD) treated with vedolizumab and ustekinumaben_US
dc.typeConference Proceeding
dc.identifier.doi10.1093/ecco-jcc/jjab076.510en_US
pubs.issueSupplement_1en_US
pubs.notesNot knownen_US
pubs.volume15en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record